What are cinnamon’s main drawbacks?

Last Updated:

The main drawback is that the current evidence underpinning the clinical benefits of cinnamon is derived from studies with small sample sizes and low methodological quality (many studies lack a control group, do not blind the participants or investigators from the treatment, and are funded or authored by manufacturers of cinnamon-containing products).[1][2][3][4][5][6][7] Consequently, large high-quality clinical trials are needed to make firm conclusions about cinnamon's health benefits in humans.

A further drawback is that several studies investigating the effect of cinnamon supplements on blood glucose, lipids, and blood pressure (see What are cinnamon’s main benefits?) do not report the participants’ dietary habits (daily energy intake) or physical activity levels (daily energy expenditure). This is problematic, because several such studies also report weight loss in the cinnamon treatment groups, which could be interpreted to mean that cinnamon causes weight loss.[8][9][10][11] However, without information about daily energy intake/expenditure, the direct effects of cinnamon supplementation on changes in body weight are unclear. Furthermore, because weight loss independently improves blood glucose, lipids, and blood pressure, this further complicates the interpretation of cinnamon’s direct effect on such variables and underlines the urgent need for well-controlled clinical trials in this field.

Cinnamon also has some safety concerns. Firstly, ingesting large amounts of cinnamon can cause gastrointestinal issues (diarrhea, nausea, and vomiting).[12][13] Secondly, cinnamon contains coumarin,[14][15][16][17] which can cause liver damage and interfere with blood clotting if ingested in sufficient amounts.[18][13][19] For this reason, cinnamon might interact negatively with blood-thinning medications and hepatotoxic drugs and be harmful to people with liver conditions. However, these potential interactions have not been well studied. Because cinnamon can also lower blood glucose and blood pressure (see What are cinnamon’s main benefits?), it is possible that cinnamon could interact with glucose-lowering and blood-pressure-lowering drugs; however, such interactions have not been investigated.

Despite the above-described concerns, adverse reactions caused by ingesting cinnamon are rare and generally mild,[2][12][13][20] and cinnamon is considered to be safe for consumption at the levels typically consumed.[18][13][21]

References
1.^Krittanawong C, Isath A, Scott CZ, Wang Z, Kaplin S, Jneid H, Lavie CJ, Virani SSAssociation Between Cinnamon Consumption and Risk of Cardiovascular Health: A Systematic Review and Meta-Analysis.Am J Med.(2022 Jan)
2.^Leach MJ, Kumar SCinnamon for diabetes mellitus.Cochrane Database Syst Rev.(2012 Sep 12)
7.^Natalia Vallianou, Catherine Tsang, Mohsen Taghizadeh, Amirhossein Davoodvandi, Sadegh JafarnejadEffect of cinnamon (Cinnamomum Zeylanicum) supplementation on serum C-reactive protein concentrations: A meta-analysis and systematic reviewComplement Ther Med.(2019 Feb)
8.^Navid Jamali, Mohammad Jalali, Javad Saffari-Chaleshtori, Mohammad Samare-Najaf, Ali SamarehEffect of cinnamon supplementation on blood pressure and anthropometric parameters in patients with type 2 diabetes: A systematic review and meta-analysis of clinical trialsDiabetes Metab Syndr.(Mar-Apr 2020)
9.^Keramati M, Musazadeh V, Malekahmadi M, Jamilian P, Jamilian P, Ghoreishi Z, Zarezadeh M, Ostadrahimi ACinnamon, an effective anti-obesity agent: Evidence from an umbrella meta-analysis.J Food Biochem.(2022 Aug)
10.^Zeinab Yazdanpanah, Maryam Azadi-Yazdi, Hadis Hooshmandi, Nahid Ramezani-Jolfaie, Amin Salehi-AbargoueiEffects of cinnamon supplementation on body weight and composition in adults: A systematic review and meta-analysis of controlled clinical trialsPhytother Res.(2020 Mar)
11.^Seyed Mohammad Mousavi, Jamal Rahmani, Hamed Kord-Varkaneh, Ali Sheikhi, Bagher Larijani, Ahmad EsmaillzadehCinnamon supplementation positively affects obesity: A systematic review and dose-response meta-analysis of randomized controlled trialsClin Nutr.(2020 Jan)
12.^Serawit Deyno, Kassahun Eneyew, Sisay Seyfe, Naasson Tuyiringire, Emanuel L Peter, Rekik Ashebir Muluye, Casim Umba Tolo, Patrick Engeu OgwangEfficacy and safety of cinnamon in type 2 diabetes mellitus and pre-diabetes patients: A meta-analysis and meta-regressionDiabetes Res Clin Pract.(2019 Oct)
13.^Hajimonfarednejad M, Ostovar M, Raee MJ, Hashempur MH, Mayer JG, Heydari MCinnamon: A systematic review of adverse eventsClin Nutr.(2019 Apr)
15.^Wang YH, Avula B, Nanayakkara NP, Zhao J, Khan IACassia cinnamon as a source of coumarin in cinnamon-flavored food and food supplements in the United StatesJ Agric Food Chem.(2013 May 8)
16.^Iwata N, Kainuma M, Kobayashi D, Kubota T, Sugawara N, Uchida A, Ozono S, Yamamuro Y, Furusyo N, Ueda K, Tahara E, Shimazoe TThe Relation between Hepatotoxicity and the Total Coumarin Intake from Traditional Japanese Medicines Containing Cinnamon Bark.Front Pharmacol.(2016)
18.^Gu DT, Tung TH, Jiesisibieke ZL, Chien CW, Liu WYSafety of Cinnamon: An Umbrella Review of Meta-Analyses and Systematic Reviews of Randomized Clinical Trials.Front Pharmacol.(2021)
20.^Calapai G, Miroddi M, Mannucci C, Minciullo P, Gangemi SOral adverse reactions due to cinnamon-flavoured chewing gums consumption.Oral Dis.(2014 Oct)
21.^Luísa L Gonçalves, Tânia Fernandes, Maria Alexandra Bernardo, José A BritoAssessment of Human Health Risk of Toxic Elements Due to Cinnamon Ingestion in the DietBiol Trace Elem Res.(2019 Jun)